All Lobbyists
Select methods...
Lobbying Records (Page 1 of 1)
AstraZeneca Pharmaceuticals (Ireland) DAC
2025-01-21
Intent: Alexion - Discuss manifesto development process and policy actions to improve outcomes for rare disease patients, including faster access to orphan medicines
Details: Alexion -Prioritisation of rare disease by next government
Officials: Peter Harper, Stephen Evans
Methods: Progress against Programme of Government deliverables for rare diseases, and case for action by next government - Email